Spinocerebellar Ataxia clinical trials at UCSF

1 in progress, 0 open to eligible people

Troriluzole in Adult Participants With Spinocerebellar Ataxia
Sorry, in progress, not accepting new patients
The purpose of this study is to compare the efficacy of Troriluzole (200 mg once daily) versus placebo after 48 weeks of treatment in subjects with spinocerebellar ataxia (SCA).
San Francisco, California and other locations

Last updated: January 2025